- Effect of romosozumab in premenopausal women with severe osteoporosis and anorexia nervosa
-
Fujimoto K, Maki N, Hashiba D, Maeyama T, Nakagawa R, Arai H, Ohtori S
- KMID: 2552869
- Osteoporos Sarcopenia.
- 2023 Dec;9(4):137-141.
- doi: 10.1016/j.afos.2023.10.001
Objectives: This study aims to investigate the effects of romosozumab on bone mineral density (BMD) and bone metabolism. Methods: In this retrospective case series, romosozumab was administered to 5 premenopausal female... -
- CITED
-
- Close
- SHARE
-
- Close
- Bone mineral metabolism and different indices of skeletal health of Ladakhi women living at high altitude
-
Babu LK, Shaw S, Ghosh D
- KMID: 2552868
- Osteoporos Sarcopenia.
- 2023 Dec;9(4):131-136.
- doi: 10.1016/j.afos.2023.11.001
Objectives: High altitude possesses a great challenge for human survival owing to low oxygen tension and has been reported to cause bone deterioration among sojourns of high altitude. The bone... -
- CITED
-
- Close
- SHARE
-
- Close
- Assessment of quality of life and its affecting factors in osteosarcopenic individuals in the Iranian older adult population: Bushehr Elderly Health (BEH) program
-
Vahdani AM, Sanjari M, Fahimfar N, Ebrahimpur M, Shafiee G, Khalagi K, Mansourzadeh MJ, Nabipour I, Larijani B, Ostovar A
- KMID: 2552870
- Osteoporos Sarcopenia.
- 2023 Dec;9(4):142-149.
- doi: 10.1016/j.afos.2023.12.002
Objectives: This cross-sectional study, conducted as part of the Bushehr Elderly Health program stage II in Bushehr, Iran, aimed to evaluate health-related quality of life (HR-QoL) in individuals aged ≥... -
- CITED
-
- Close
- SHARE
-
- Close
- Teriparatide and etelcalcetide improve bone, fibrosis, and fat parameters in chronic kidney disease model rats
-
Igarashi S, Kasukawa Y, Nozaka K, Tsuchie H, Abe K, Saito H, Shoji R, Kasama F, Harata S, Okamoto K, Oya K, Miyakoshi N
- KMID: 2552867
- Osteoporos Sarcopenia.
- 2023 Dec;9(4):121-130.
- doi: 10.1016/j.afos.2023.11.002
Objectives: Chronic kidney disease (CKD) complicated by secondary hyperparathyroidism (SHPT) is associated with an increased risk of fragility fractures. Etelcalcetide (EC) is a treatment for SHPT that reduces serum parathyroid... -
- CITED
-
- Close
- SHARE
-
- Close
- Musculoskeletal and neurocognitive clinical significance of adult hypophosphatasia
-
Kim SM, Korkmaz F, Sims S, Ryu V, Yuen T, Zaidi M
- KMID: 2552866
- Osteoporos Sarcopenia.
- 2023 Dec;9(4):115-120.
- doi: 10.1016/j.afos.2023.12.003
Hypophosphatasia (HPP), also called Rathbun disease, is a rare genetic disorder that is caused by the loss-of-function mutation in the ALPL gene encoding tissue nonspecific alkaline phosphatase. Doctor Rathbun first... -
- CITED
-
- Close
- SHARE
-
- Close
- Pain score as a predictor of subsequent fragility fracture in postmenopausal patients with rheumatoid arthritis: A retrospective case-control study
-
Yoshii I, Sawada N, Chijiwa T
- KMID: 2552871
- Osteoporos Sarcopenia.
- 2023 Dec;9(4):150-156.
- doi: 10.1016/j.afos.2023.12.001
Objectives: Bone fragility fracture (BFF) is a serious incident in treating rheumatoid arthritis (RA). We hypoth esized that pain degree during treatment RA correlated with incident BFF and validated how... -
- CITED
-
- Close
- SHARE
-
- Close
